Combination Products Summit 2025 has been announced!

November 13-14, 2025

Providence, RI

AFDO RAPS Healthcare Products Collaborative
Presents
Combination Products Summit

Combination Products Summit took place October 9th to 10th, 2024

Providence, RI

Agenda from 2024

If you missed the summit, here’s what we covered:

October 8, 2024 @ 9:00 am

5:15 pm

Other

Moderators

Chin-Wei Soo, Global Regulatory Head, Devices and Combination Products, Genentech/Roche

Jason Lipman, Senior Director, Global Regulatory Affairs, Devices and Combination Products, Sanofi

Hemal Mehta, Associate Director, Global CMC Regulatory Affairs, Medical Devices & Combination Products, Johnson & Johnson

Ryan McGowan, Director, Digital Devices and Combination Products, AstraZeneca

Ryan Hoshi, Director, Regulatory Policy and Intelligence, AbbVie, Inc.

October 8, 2024 @ 10:00 am

2:00 pm

Other

Speakers

James Bertram, Director, Office of Combination Products (OCP), U.S. Food and Drug Administration 

Patricia LoveDeputy Director, Office of Combination Products, FDA 

Annette MarthalerSenior Regulatory Counsel, Office of Combination Products, FDA 

Stephanie Shapley, Associate Director for Policy, Office of Combination Products, FDA 

October 9, 2024 @ 7:00 am

8:00 am

Other

October 9, 2024 @ 8:00 am

8:30 am

General

Moderator

Kim Belsky, Strategic Facilitator, Combination Products Summit, AFDO/RAPS Healthcare Products Collaborative

October 9, 2024 @ 8:30 am

9:15 am

General

Moderators

Khaudeja Bano, Vice President Combination Product Quality, Ex Amgen
Fran DeGrazio, Principal Consultant, Strategic Parenteral Solutions LLC
James Wabby, Global Head – Emerging Technologies, Combination Products, and Devices, AbbVie Inc.

October 9, 2024 @ 9:15 am

10:00 am

General

Moderator

Kim Belsky, Strategic Facilitator, Combination Products Summit, AFDO/RAPS Healthcare Products Collaborative

Speakers

James Bertram, Director of the Office of Combination Products (OCP), FDA
Danita Dixon, Associate Director for Information Management, Office of Clinical Policy and Programs, Office of the Commissioner, FDA

October 9, 2024 @ 10:00 am

10:25 am

Other

October 9, 2024 @ 10:25 am

11:25 am

General

Moderators

Bonnie OdomPartner in the Healthcare and Life Sciences Practice, Epstein Becker & Green
Chin-Wei Soo, Global Regulatory Head, Devices and Combination Products, Genentech/Roche

Speakers

Juliane Lessard, Director, Division of Drug Delivery, General Hospital Devices, and Human Factors, Center for Devices and Radiological Health,(CDRH), FDA
Shruti Mistry, Assistant Director, Injection Devices Team, Center for Devices and Radiological Health (CDRH), FDA
Renato Ravanello, Senior Director, Device Development, Genentech
Nathalie Vandenkoornhuyse, Executive Vice President, Regulatory Affairs, Coherus

October 9, 2024 @ 11:25 am

12:25 pm

General

Moderators

Ryan McGowan, Director, CMC Regulatory Affairs, AstraZeneca
Rumi Young, Director, Regulatory Policy, Novo Nordisk

Speakers

Kristin Benokraitis, Global Head of RegCMC Device and Combination Products, Biogen
Ashley Boam, Director Office of Policy for Pharmaceutical Quality, Office of Policy, Center for Drug Evaluation and Research (CDER), FDA
John McMichael, Director, Medical Devices & Combination Products, AstraZeneca
Sarah Mollo, Combination Products Analyst, Center for Devices and Radiological Health (CDRH), FDA 
Suzette Roan, Associate, VP, Head of Global Regulatory Affairs Devices, Sanofi

October 9, 2024 @ 12:25 pm

1:40 pm

General

October 9, 2024 @ 1:40 pm

2:25 pm

General

Moderator

Andrea Redd, Associate Vice President, Global Regulatory Affairs, Drug Delivery & Combination Products, Eli Lilly

Speakers

Brian Neely, Chemist, Center for Drug Evaluation and Research (CDER), FDA 
Andrew Fine, Senior Advisor in Division of Clinical Review in Office of Generic Drugs (OGD), Center for Drug Evaluation and Research (CDER), FDA
Chirag Walawalkar, Director, Device Design & Process Development, Merck 

October 9, 2024 @ 2:25 pm

3:25 pm

General

Moderator

Ryan Hoshi, Director, Regulatory Policy & Intelligence, AbbVie, Inc.

Speakers

Tina Kiang, Director, Division of Regulation and Guidance (DRG), Office of Policy for Pharmaceutical Quality (OPPQ), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), FDA
Juliane Lessard, Director, Division of Drug Delivery, General Hospital Devices, and Human Factors, Center for Devices and Radiological Health (CDRH), FDA 
Chelsea O’Connell, Director, Global Regulatory and R&D Policy, Amgen
Jiaying Shen, Distinguished Scientist, Medical Device and Combination Product Development, Regulatory and Quality, Merck
Lisa Wright, Director of Regulatory Policy, Novo Nordisk

October 9, 2024 @ 3:25 pm

3:50 pm

Other

October 9, 2024 @ 3:50 pm

4:50 pm

General

Moderators

Bonnie Odom, Partner in the Healthcare and Life Sciences Practice, Epstein Becker & Green

Tine Albeck, Senior QA Professional, ALK A/S

Speakers

Khaudeja Bano, Past Amgen
Sara Coon, Director Regulatory Affairs, Halozyme, Inc
Nik Thakur, Senior Program Manager, Quality and Compliance, Center for Devices and Radiological Health (CDRH), FDA

October 9, 2024 @ 4:50 pm

5:00 pm

General

Moderator

Kim BelskyStrategic Facilitator, Combination Products Summit, AFDO/RAPS Healthcare Products Collaborative

October 9, 2024 @ 5:30 pm

7:00 pm

General

October 10, 2024 @ 7:00 am

8:00 am

Other

October 10, 2024 @ 8:00 am

8:10 am

General

Moderator

Kim BelskyStrategic Facilitator/MedCon-Combination Products Summit, AFDO/RAPS Healthcare Products Collaborative

October 10, 2024 @ 8:10 am

9:10 am

General

Moderators

Rumi Young, Director, Regulatory Policy, Novo Nordisk

Andrea Redd, Associate Vice President, Global Regulatory Affairs, Drug Delivery & Combination Products, Eli Lilly

Speakers

Ashley Boam, Director Office of Policy for Pharmaceutical Quality, Office of Policy, Center for Drug Evaluation and Research (CDER), FDA
Juliane Lessard, Director, Division of Drug Delivery, General Hospital Devices, and Human Factors, Center for Devices and Radiological Health,(CDRH), FDA 
Sarah Mollo, Combination Products Analyst, Center for Devices and Radiological Health (CDRH), FDA
Jiaying Shen, Distinguished Scientist, Medical Device and Combination Product Development, Regulatory and Quality, Merck
Alan Stevens, Global Head of Complex Devices and Drug Delivery Systems, RA CMC Devices, AbbVie, Inc.

October 10, 2024 @ 9:10 am

10:10 am

General

Moderator

Ryan McGowan, Director, CMC Regulatory Affairs, AstraZeneca

Speakers

Tim Chesworth, Senior Director, CMC Regulatory Affairs, AstraZeneca
Isabelle Clamou, Policy Officer, European Commission
Olga Tkachenko, Policy Officer, European Commission

October 10, 2024 @ 10:10 am

10:35 am

Other

October 10, 2024 @ 10:35 am

11:20 am

General

Moderator

Shannon Hoste, Chief Scientific Officer for Pathway for Patient Health

Speakers

Natalie Abts, Head of Human Factors Engineering Device and Packaging Development, Genentech
Kristina Lauritsen, Combination Products Regulator, Center for Drug Evaluation and Research (CDER), FDA
Patricia Love, Deputy Director, Office of Combination Products, FDA
Jenny Wu, Associate Director, Human Factors, AstraZeneca

October 10, 2024 @ 11:20 am

12:20 pm

General

Moderator

James Wabby, Head, Global Regulatory Affairs, Emerging Technologies, Combination Products, and Devices, AbbVie, Inc.

Speakers

Jonathan Amaya-Hodges, Director, Technical Services, Suttons Creek
Anjali Atal-Gupta, Director Regulatory Affairs – Cell Therapy Device Development, Novo Nordisk
Andrea Gray, Biomedical Engineering Advisor, Center for Biologics Evaluation and Research (CBER), FDA
Alex Lyness, Business Development Director – Drug Delivery, TTP PIc
Jerzy Wojcik, VP Regulatory and Quality Services, Edgeone Medical (CDMO)

October 10, 2024 @ 12:20 pm

1:20 pm

Other

October 10, 2024 @ 1:20 pm

2:00 pm

General

Moderator

Ryan Hoshi, Director, Regulatory Policy & Intelligence, AbbVie, Inc.

Speakers

James Bertram, Director of the Office of Combination Products (OCP), FDA 
Kristina Lauritsen, Combination Products Regulator, Center for Drug Evaluation and Research (CDER), FDA
Jill Lee, Senior Director, Regulatory Policy, Novo Nordisk
Annette Marthaler, Senior Regulatory Counsel, Office of Combination Products (OCP), FDA
Chelsea O’Connell, Director, Global Regulatory and R&D Policy, Amgen
Andrew Yeatts, Combination Product Policy Analyst, Center for Devices and Radiological Health (CDRH), FDA 

October 10, 2024 @ 2:00 pm

3:00 pm

General

Moderators

Jason Lipman, Senior Director, Global Regulatory Affairs, Devices and Combination Products, Sanofi
Rumi Young, Director, Regulatory Policy, Novo Nordisk

Speakers

James Bertram, Director of the Office of Combination Products (OCP), FDA
Ashley Boam, Director Office of Policy for Pharmaceutical Quality, Office of Policy, Center for Drug Evaluation and Research (CDER), FDA
Andrea Gray, Biomedical Engineering Advisor, Center for Biologics Evaluation and Research (CBER), FDA
Tina Kiang, Director, Division of Regulation and Guidance (DRG), Office of Policy for Pharmaceutical Quality (OPPQ), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), FDA
Kristina Lauritsen, Combination Products Regulator, Center for Drug Evaluation and Research (CDER), FDA
Juliane Lessard, Director, Division of Drug Delivery, General Hospital Devices, and Human Factors, Center for Devices and Radiological Health (CDRH), FDA 
Patricia Love, Deputy Director, Office of Combination Products, FDA
Annette Marthaler, Senior Regulatory Counsel, Office of Combination Products, FDA
Sarah Mollo, Combination Products Analyst, Center for Devices and Radiological Health (CDRH), FDA
Stephanie Shapley, Associate Director for Policy, Office of Combination Products, FDA 
Nik Thakur, Senior Program Manager, Quality and Compliance, Center for Devices and Radiological Health (CDRH), FDA
Andrew Yeatts, Combination Product Policy Analyst, Center for Devices and Radiological Health (CDRH), FDA

October 10, 2024 @ 3:00 pm

3:10 pm

General

Moderator

Kim Belsky, Strategic Facilitator, Combination Products Summit, AFDO/RAPS Healthcare Products Collaborative

This conference IS co-sponsored by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services. The contents are those of the presenters and do not necessarily represent the official views of, nor an endorsement by, FDA/HHS or the U.S. government.

The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials and the Regulatory Affairs Professionals Society. Learn more.

Newsletter

Stay in the know about upcoming events and breaking news from the collaborative.

Subscribe

ContACT Us

Have questions about our events, registration, CEU's, sponsorship, or something else?

Get in touch

© 2024 AFDO/RAPS Healthcare Products Collaborative